John S Albin, M.D., Ph.D.
|
Clinicn Investigator, Instruct Infectious Disease, Mass General Research Institute |
|
Instructor in Medicine Harvard Medical School |
|
Assistant In Medicine Infectious Disease, Massachusetts General Hospital |
| MD University of Minnesota Medical School 2014 |
| PhD University of Minnesota 2012 |
Research Interests
Research Narrative
Dr. Albin is using chemical approaches to develop peptide-based antibiotics, including antibody-bactericide conjugates for the modulation of known antimicrobial agents and synthetic evolution of peptides for the derivation of novel antimicrobial peptides. In this work, he is specifically targeting Pseudomonas aeruginosa, an opportunistic pathogen that commonly affects immunocompromised hosts, including those with cystic fibrosis and neutropenia.